Elsayed S. Moubarak: Evaluating Established and Emerging Biomarkers in Hemophilia A and B Management
Elsayed S. Moubarak, Member of NEGIDA Corporation, Researcher at Research Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m pleased to share that our recent review article has been published in ASIDE Internal Medicine.
In this narrative review, we explored established and emerging biomarkers in Hemophilia A and B, highlighting their diagnostic, prognostic, and therapeutic implications in the era of extended half-life therapies, non-factor treatments, and gene therapy.
The review discusses:
- FVIII/FIX activity assays and inhibitor testing
- Genotyping approaches
- Global hemostasis assays
- Pharmacokinetic-guided prophylaxis
- Novel inflammatory and angiogenic markers linked to arthropathy
I am honored to contribute as Second Author and Corresponding Author on this work.
Grateful to my co-authors for their collaboration and dedication.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Read the Full Article on ASIDE Internal Medicine Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge